Safety and Efficacy Study of SHAPE Gel in Alopecia Areata
NCT02636244 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2016-10-20
Summary
The purpose of this study is to evaluate the efficacy and safety of SHAPE Gel applied topically to adult patients with alopecia areata of the scalp.
Conditions
Interventions
- DRUG
-
SHAPE Gel
Sponsors & Collaborators
-
TetraLogic Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-28
- Primary Completion
- 2017-08-31
- Completion
- 2018-01-31
More Related Trials
-
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
NCT03594227 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
NCT03662854 ·Status: UNKNOWN ·Phase: PHASE1
-
Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
NCT02684123 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia
NCT01286649 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up
NCT02547363 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia
NCT01501617 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
LEO 124249 Ointment in the Treatment of Alopecia Areata
NCT02561585 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Safety and Efficacy of Autologous Human Platelet Lysate for Treatment of Androgenetic Alopecia
NCT01643629 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata
NCT03137381 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
NCT00408798 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
NCT07012486 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Phase II Study in Patients With Alopecia Areata
NCT04346316 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata
NCT05556265 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy & Safety of Minoxidil SL Tablets in Men With AGA
NCT06924632 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899)
NCT01451112 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
NCT06826196 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
NCT04784533 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Of AGE ZERO™ EXOSOMES To Treat Men and Women With Androgenetic Alopecia
NCT06482541 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
NCT02553330 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512)
NCT01451125 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA
NCT06393452 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia
NCT03048461 ·Status: WITHDRAWN ·Phase: PHASE2
-
Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
NCT07107841 ·Status: RECRUITING ·Phase: NA
-
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
NCT03898479 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
NCT03354637 ·Status: TERMINATED ·Phase: PHASE2